{
    "2021-05-05": [
        [
            {
                "time": "2021-05-04",
                "original_text": "AmerisourceBergen Stock Dives After Q2 Earnings Fall Short Of Expectations",
                "features": {
                    "keywords": [
                        "AmerisourceBergen",
                        "Q2 Earnings",
                        "Fall Short",
                        "Expectations"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-05-04",
                "original_text": "Eli Lilly Under FDA Scrutiny At Its COVID-19 Drug Manufacturing Facilities Amid Staff Accusations: Reuters",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "FDA Scrutiny",
                        "COVID-19 Drug",
                        "Staff Accusations"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-05-04",
                "original_text": "Lilly hit by staff accusations, FDA scrutiny at COVID drug factories",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Staff Accusations",
                        "FDA Scrutiny",
                        "COVID Drug Factories"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-05-04",
                "original_text": "Lilly to Participate in Bank of America Securities 2021 Health Care Conference",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Bank of America Securities",
                        "Health Care Conference"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-04",
                "original_text": "Exclusive: Lilly hit by staff accusations, FDA scrutiny at COVID drug factories",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Staff Accusations",
                        "FDA Scrutiny",
                        "COVID Drug Factories"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-05-04",
                "original_text": "Why Eli Lilly Is Still a Top Stock for 2021",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Top Stock",
                        "2021"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}